iNitrile

Automatic Disposable Glove Dispenser

iNitrile

Automatic Disposable Glove Dispenser

Houston, TX
Health Tech
iNitrile is the creator of an innovative glove dispensing machine that eliminates the risk of viral contamination, streamlines processes, and minimizes product waste. Scan your RFID badge, disinfect your hand, insert it in the machine and you are good to go! It is that simple. We thrive to overcome challenges by inventing revolutionary technologies. Our approach is focused on safety, automation, and inventory optimization while improving the user experience accessing and utilizing disposable gloves.

$8,354

raised
34
Investors
$50M
Valuation
$1.95
Price per Share
$101.40
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
Reg CF
Offering

$8,354

raised
34
Investors
$50M
Valuation
$1.95
Price per Share
$101.40
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
Reg CF
Offering

Rewards

Get rewarded for investing more into iNitrile:

$101+
Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$5,000+
Investment
$5,000+
Invest $5,000+ and receive 5% bonus shares on your investment.
$10,000+
Investment
$10,000+
Invest $10,000+ and receive 10% bonus shares on your investment.

Reasons to Invest

The global personal protective equipment market is expected to reach $123.38 billion by 2027 registering a CAGR of 9.6%.
The sky-high freight prices, strict FDA inspection guidelines for PPE cargo, and other political sanctions have caused a huge shortage of PPE products, especially gloves. The need for domestic production of PPE is more urgent than ever.
iNitrile glove dispenser technology will allow the company to secure a large market share versus other factory plants that can only offer the production of nitrile gloves.

Overview


We Revolutionize Putting on Gloves


Putting on gloves without contamination is possible -  it can be done simply and quickly.


*This image is of iNitrile's prototype device, which is currently in development and not yet available on the market. 



iNitrile’s innovative approach normalizes PPE protocols in the workplace by minimizing waste, cost, and on-premise risk of infection for various business sectors across the United States. 


One of the main drivers for iNitrile is the passion for innovation and the commitment with our clients for the improvement to their daily lives. Our team is distinguished by seeking the latest technological advances to apply them in the development of machines combining technology, innovation and user experience.


Access to universal health requires investment and protection at all times, not only during health emergencies, as this type of investment pays off generously in terms of health, employment, and economic and social opportunities. iNitrile is committed to ensuring safe and decent working conditions for our healthcare workers, and to protecting their physical and mental health by being aware that all safety measures are taken.


THE PROBLEM


Viral Contamination is a real risk, and traditional methods of putting on gloves increase that risk.

 

Many industries such as medical, food and beverage, cosmetics and entertainment are required to use gloves on a daily basis. This high consumption of gloves created the need to develop a solution to automate the process. 


The iNitrile team recognized the urgent need for the market to have an automated system to dispense gloves, eliminate contamination risk and track usage efficiently.

gi


*Images used in this video are in the prototype phase. Product is not currently available on the market. 




THE SOLUTION


Hello New World of Sterilization

The iNitrile machine is focused on improving five key areas. First is safety via its contactless approach eliminating infection and contamination risks. Second is traceability via its built-in AI-based technology. Third is inventory management via its built-in cloud-based software. Fourth is product usage optimization via its dispensing technology, which eliminates glove tears. Fifth is user experience when accessing and utilizing gloves. 


Our product is simple: it dispatches nitrile gloves automatically without human contact. Nitrile gloves are used in the healthcare sector because they are made of synthetic rubber, versus latex gloves which a lot of people are sensitive to. The iNitrile glove dispenser contains cartridges that place the gloves directly on the user’s hands - reducing contamination. 

gif

*These images are of iNitrile's prototype device, which is currently in development and not yet available on the market. 


We believe this technology will greatly improve sterilization rates, as well as prevent inadvertent infection from being transmitted within a workplace or venue.



OUR TRACTION


We are taking the industry by storm



The Average Over Value for our business model is in the range of 1 million Nitrile gloves, of course, considering the growing curve of the demand in our product.


Our cost of goods sold reflects the great skills of the management team with special care in the whole process and the materials used. Therefore, our cost of goods sold is in the range of 1.60 to 1.88 cents.


Lastly, our Gross margin is 77% on average.


In The Media


Texas Medical Technology Launches Its Smart iNitrile Device for Putting on Gloves Easily, Safely, and Automatically

iNitrile glove dispenser ensures organizations considerably enhance upon their very own security protocols amidst a pandemic. A simply accessible and plentiful provide of disposable gloves will significantly enhance sterilization charges, in addition to prevent inadvertent infection from being transmitted inside an office or venue. The continued use of the gadget helps organizations obtain important financial savings in working prices, lowering as much as 40 p.c in glove waste over the primary 12 months of operation. iNitrile’s built-in, cloud-based, administration software program permits enterprises to streamline inventory administration by managing the utilization course of and provide ranges. (Source, Source, Source





THE MARKET


One Step Ahead 


The global disposable glove market was valued at USD $10.17 billion in 2020 and is expected to grow at a CAGR of 9.2% from 2020 to 2028. (Source)




*These are estimated profit numbers based on company data.


Growing demand for disposable gloves in medical & healthcare, pharmaceutical, automotive, chemical, and oil & gas industries has been a major driving factor for market growth.


With this in mind, nitrile emerged as the primary material used for disposable gloves due to its latex-free, chemical resistance and long shelf life.


This product does not currently exist in the market and creates an innovative solution for a daily problem; iNitrile does not have any competitors.


Why Invest


We Create a Solution for an Everyday Problem


The COVID-19 pandemic shed light on risks that have been previously overlooked and accepted. Frontline workers and healthcare professionals should not have to risk their own health in order to treat patients. 

Everyone deserves a safe and hygienic work environment, which is a core principle of our mission. We aim to have our products placed in every American hospital and eventually in every business or venue in need of gloves around the world.



We believe iNitrile will help reduce errors and waste and help create a safer, healthier world.



Insert Image
Drop image
(or click)

Loading image

In the Press

Business Wire

Texas Medical Technology Launches Its Smart iNitrile Device for Putting on Sterile Gloves Easily, Safely, and Automatically

Yahoo

Texas Medical Technology Launches Its Smart iNitrile Device for Putting on Sterile Gloves Easily, Safely, and Automatically

iEmpresarial

Texas Medical Technology Launches Its Smart iNitrile Device for Putting on Sterile Gloves Easily, Safely, and Automatically

Opera News

Texas Medical Technology Launches Its Smart iNitrile Device for Putting on Sterile Gloves Easily, Safely, and Automatically

RT Sleep World

New Device for Putting on Sterile Gloves Automatically

C TECH

How an Israeli turned Covid-19 into a million-dollar win for medical supplies

Fox News

Palestinian, two Israelis come together in hopes of making Houston the glove manufacturing center of the world

The Times of Israel

2 Israelis and a Palestinian American set up automated surgical glove dispenser

Offering Summary


Company

:

iNitrile, Inc.

Corporate Address

:

6115 Skyline Dr. Suite C, Houston, TX 77057

Offering Minimum

:

$9,999.60

Offering Maximum

:

$1,069,998.15

Minimum Investment Amount

(per investor)

:

$101.40











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

5,128

Maximum Number of Shares Offered

:

548,717

Price per Share

:

$1.95

Pre-Money Valuation

:

$50,001,750.00











*Maximum number of shares offered subject to adjustment for bonus shares. See bonus info below.

Voting Rights of Securities Sold in this Offering

Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.

Investment Incentives and Bonuses*

Time-Based

Friends and Family Early Birds

Invest within the first 48 hours and receive an additional 10% bonus shares.

Super Early Bird Bonus

Invest within the next 72 hours and receive an additional 7% bonus shares.

Early Bird Bonus

Invest within the next 7 days and receive an additional 5% bonus shares.

Amount-Based:

$5,000+ 

Invest $5,000+ and receive 5% bonus shares on your investment.

$10,000+ 

Invest $10,000+ and receive 10% bonus shares on your investment. 

*All perks occur when the offering is completed.

The 10% StartEngine Owners' Bonus

iNitrile, Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $1.75 / share, you will receive 110 shares of Common Stock, meaning you'll own 110 shares for $175. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

Irregular Use of Proceeds

Example - The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments and salary made to one's self, a friend or relative; Any expense labeled "Administration Expenses" that is not strictly for administrative purposes; Any expense labeled "Travel and Entertainment"; Any expense that is for the purposes of inter-company debt or back payments.

Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$41,029.00 USD
$0.00 USD
Cash And Cash Equivalents
$5,166.00 USD
$0.00 USD
Accounts Receivable
$0.00 USD
$0.00 USD
Short Term Debt
$19,213.00 USD
$0.00 USD
Long Term Debt
$153,523.00 USD
$0.00 USD
Revenues And Sales
$0.00 USD
$0.00 USD
Costs Of Goods Sold
$0.00 USD
$0.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$131,707.00 USD
$0.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

We are at the Medtrade East Expo!

6 days ago

We are excited to announce that we have a booth set up at the Medtrade East Expo.  It is held at the Georgia World Congress Center in Atlanta, Georgia from October 18-20.  Medtrade is the largest home medical equipment trade show and conference in the US, and is filled with the leading home medical equipment manufacturers, HME technology, and personal health products. 


Omri Shafran, CEO (right), Sean Rybar, co-founder and partner (left), and Amber Fallman, VP of Sales, are on the expo floor representing iNitrile and educating peers on how iNitrile will be the future of disposable gloves.  



iNitrile will gain exposure and sourcing opportunities to satisfy today’s growing demand in an ever-changing environment!  

Thank you for the support,

iNitrile Team 



Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
Please use Updates for communications.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}